Skip to content

A clinical study for renal microcirculatory alterations in Sepsis

A clinical study for renal microcirculatory alterations in Sepsis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018221
Enrollment
Unknown
Registered
2018-09-05
Start date
2018-09-04
Completion date
Unknown
Last updated
2018-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis,septic shock,Acute kidney injury

Interventions

Group 1:Norepinephrine
Group 2:Terlipressin

Sponsors

the Fourth Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The patient was admitted to ICU in the fourth hospital of Hebei Medical University, And the patients with sepsis or septic shock conformed to the sepsis 3.0 guidelines.

Exclusion criteria

Exclusion criteria: Age 50 mmHg, Intra-abdominal hypertension, intolerance to Sonovue or any other ultrasound contrast agent,inability to obtain contrast enhanced ultrasound medium use of informed consent,The image of contrast-enhanced ultrasound is not clear enough to be effectively measured,enrolment in other research study.

Design outcomes

Primary

MeasureTime frame
Incidence of acute kidney injury;Duration of acute kidney injury;Incidence of renal replacement therapy;Duration of renal replacement therapy;

Secondary

MeasureTime frame
Mortality in ICU;Hospital mortality;28-day motality;Dependency rate of renal replacement therapy in 28 day;90-day motality;Dependency rate of renal replacement therapy in 90 day;

Countries

China

Contacts

Public ContactLixia Liu

the Fourth Hospital of Hebei Medical University

gwxx0708@foxmail.com+86 18531117579

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026